| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,288,000 | 2,273,000 | 2,161,000 | 1,961,000 | | Cost of Revenue | 402,000 | 463,000 | 480,000 | (225,000) | | | Gross Profit | 1,886,000 | 1,810,000 | 1,681,000 | 2,186,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 80,000 | 98,000 | 97,000 | 824,000 | | Non Recurring | 49,000 | 21,000 | (6,000) | (3,000) | | Others | 821,000 | 793,000 | 709,000 | 656,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 919,000 | 898,000 | 881,000 | 709,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 531,000 | 898,000 | 881,000 | 709,000 | | Interest Expense | (252,000) | 126,000 | 126,000 | 157,000 | | Income Before Tax | 783,000 | 772,000 | 755,000 | 552,000 | | Income Tax Expense | 283,000 | 276,000 | 269,000 | 201,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 500,000 | 496,000 | 486,000 | 351,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 500,000 | 496,000 | 486,000 | 351,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $500,000 | $496,000 | $486,000 | $351,000 |
|
0.01% Nasdaq 
0.22%
Income Statement
